AHLA, American Health Lawyers Association
A A A
Home  |  Sign In  |  Contact Us  |  Job Bank
AHLA » News Center » Daily Archive » Judge dismisses Medtronic defibrillator suit Leading health law to excellence through education, information and dialogue lktw
Follow AHLA  

In Daily Archive:

AHLA ConnectionsExpand AHLA Connections
Health Lawyers WeeklyExpand Health Lawyers Weekly
Health and Life Sciences Law Daily
Health Law Digest
Health Law Documents
Press RoomExpand Press Room
    
Print this page Print this page
Email to a friend Email to a friend

      

      

           Share this Page

 

Judge dismisses Medtronic defibrillator suit 

The Wall Street Journal (1/7, Burton) reports, "A federal judge threw out lawsuits on behalf of thousands of patients with heart-defibrillator wires...concluding that a recent Supreme Court opinion made the dismissals inevitable." Citing a ruling "that federal law 'pre-empts' product-liability lawsuits under state law," U.S. District Judge Richard H. Kyle dismissed lawsuits alleging that Medtronic's Sprint Fidelis defibrillator lead caused patients to die. The lead "had been surgically implanted in 268,000 patients world-wide when" Medtronic "concluded it was fracturing at a higher rate than that of its more robust predecessor, the Sprint Quattro." Patients whose wires fractured died either "because the defibrillator failed to dispatch electrical therapy to the heart or because the massive and multiple shocks may have caused patients' hearts to stop."

        The "Food and Drug Administration (FDA) approved new wiring for the company's defibrillators" in December 2007, which Judge Kyle ruled "protects the makers from lawsuit," the AP (1/7) adds. Medtronic stated that "the decision was consistent with a Supreme Court ruling" in favor of the company last year. In that suit, Medtronic was "sued because a patient suffered from a burst balloon catheter during an angioplasty procedure." The court decided that "the plaintiffs' claims were pre-empted because the FDA had approved the catheter."

        Commenting on Judge Kyle's ruling, Medtronic CEO Bill Hawkins "said the decision supports the principle that the [FDA] is the appropriate body to determine the safety and efficacy of innovative technologies," Minnesota's Star Tribune (1/7, Moore) notes. The Wall Street Journal (1/6, Goldstein) Health Blog also covered the story.

 

 

Copyright © 2008 by Custom Briefings | 11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191

 


 
Related Resources
© 2012 American Health Lawyers Association
1620 Eye Street NW
Washington, DC  20006-4010
Phone: 202-833-1100   Fax: 202-833-1105
FAQ  |  Privacy Policy  |  Site Map